Drug Approval | September 25, 2023
Strides receives USFDA approval for Icosapent Ethyl Capsules
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD)
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD)
Dr. Jitendra Singh inaugurates 300 LPM capacity Oxygen Plant, Day Care Chemotherapy Unit affiliated to Tata Memorial Hospital & Maternal ICU at GMC Kathua
Appointment further strengthens company’s expertise in fastest-growing therapeutic area to meet patient need
InvaGen has received 5 inspectional observations in Form 483
The partnership is part of BioNTech’s strategy to develop novel prophylactic vaccines for the prevention of high-medical-need infectious diseases
The partnership acknowledges the increasing mental health challenges faced by students in today's society
Approval is for use in myelofibrosis patients with anaemia regardless of prior myelofibrosis therapy
CureVac is among many pharmaceutical companies looking to produce a novel seasonal influenza vaccine via mRNA technology
Patient Advisory Councils (PACs) to be set up across hospitals to make patients true partners in enhancing patient safety and improving care delivery
Opinion granted based on positive disease-free survival results from the Phase 3 KEYNOTE-091 trial
Subscribe To Our Newsletter & Stay Updated
